Well .... ANP has tried that a few times before targeting other indications ....
How has that worked ?
The old adage "this time could be different" ?
Still all about the DMD trial ....
2026 the spot it needs to hit if wants to see the voucher - but really if successful at that point the voucher doesn't mean much .... maybe help fund manufacturing facilities for 2027 and beyond ...
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2, page-30
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
